INTRODUCTION: Pertussis has been a preventable disease in Catalonia since 1965, but the annual number of cases remains high. The aim of this study was to analyze the epidemiology of pertussis in Catalonia and its implications for control purposes. METHODS: An epidemiological study was carried out in Catalonia between 2004 and 2008. Pertussis cases reported to the Department of Health were collected and disease reports were filled out with the case information. Incidence rates, rate ratios (RR) and their 95% confidence intervals (CI) were calculated. RESULTS: 963 cases were reported: 555 (57.6%) were confirmed and 408 (42.4%) were suspected cases. The reported incidence rate was 2.01 × 10(-5) person years in 2004 and 4.34 in 2008. The biggest increase in cases between 2004 and 2008 was observed in the ≥35 years age group (RR: 6.98; 95%CI: 2.11-36.36). 303 (31.5%) patients were hospitalized, of whom 93.7% were aged <1 year. Clinical differences were observed in paroxysmal cough (83.8% in suspected and 76.4% in confirmed cases, p=0.005), posttussive vomiting (47.1% and 36.1%, respectively, p=0.001), apnoea (13.7% and 21.3%, respectively, p=0.003) and fever (20.1% and 12.4%, respectively, p=0.001). CONCLUSION: Pertussis incidence rates increased during the study period, with the greatest increase occurring in the ≥35 years age group. A booster dose of vaccine in young people could reduce the circulation of B. pertussis in adolescents and adults and indirectly reduce the incidence in children.
INTRODUCTION: Pertussis has been a preventable disease in Catalonia since 1965, but the annual number of cases remains high. The aim of this study was to analyze the epidemiology of pertussis in Catalonia and its implications for control purposes. METHODS: An epidemiological study was carried out in Catalonia between 2004 and 2008. Pertussis cases reported to the Department of Health were collected and disease reports were filled out with the case information. Incidence rates, rate ratios (RR) and their 95% confidence intervals (CI) were calculated. RESULTS: 963 cases were reported: 555 (57.6%) were confirmed and 408 (42.4%) were suspected cases. The reported incidence rate was 2.01 × 10(-5) person years in 2004 and 4.34 in 2008. The biggest increase in cases between 2004 and 2008 was observed in the ≥35 years age group (RR: 6.98; 95%CI: 2.11-36.36). 303 (31.5%) patients were hospitalized, of whom 93.7% were aged <1 year. Clinical differences were observed in paroxysmal cough (83.8% in suspected and 76.4% in confirmed cases, p=0.005), posttussive vomiting (47.1% and 36.1%, respectively, p=0.001), apnoea (13.7% and 21.3%, respectively, p=0.003) and fever (20.1% and 12.4%, respectively, p=0.001). CONCLUSION: Pertussis incidence rates increased during the study period, with the greatest increase occurring in the ≥35 years age group. A booster dose of vaccine in young people could reduce the circulation of B. pertussis in adolescents and adults and indirectly reduce the incidence in children.
Authors: Hyo Jin Kwon; Jae-Wook Lee; Nak-Gyun Chung; Bin Cho; Hack-Ki Kim; Jin Han Kang Journal: J Korean Med Sci Date: 2011-12-19 Impact factor: 2.153
Authors: Luis Urbiztondo; Sonia Broner; Josep Costa; Laura Rocamora; José M Bayas; Magda Campins; Maria Esteve; Eva Borras; Angela Domínguez; The Working Group For The Study Of The Immune Status In Health Care Journal: Hum Vaccin Immunother Date: 2014-11-01 Impact factor: 3.452
Authors: Pere Godoy; Manuel García-Cenoz; Diana Toledo; Glòria Carmona; Joan A Caylà; Miquel Alsedà; Josep Àlvarez; Irene Barrabeig; Neus Camps; Pere Plans; María Company; Jesús Castilla; Maria-Rosa Sala-Farré; Carmen Muñoz-Almagro; Cristina Rius; Àngela Domínguez Journal: Euro Surveill Date: 2016-11-10
Authors: Hyo Jin Kwon; Sook Kyung Yum; Ui Yoon Choi; Soo Young Lee; Jong Hyun Kim; Jin Han Kang Journal: J Korean Med Sci Date: 2012-12-07 Impact factor: 2.153